SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-017624
Filing Date
2023-11-06
Accepted
2023-11-03 17:41:32
Documents
14
Period of Report
2023-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20231103x8k.htm   iXBRL 8-K 35935
2 EX-99.1 cydy-20231103xex99d1.htm EX-99.1 32420
3 GRAPHIC cydy-20231103xex99d1001.jpg GRAPHIC 3370
  Complete submission text file 0001558370-23-017624.txt   191830

Data Files

Seq Description Document Type Size
4 EX-101.SCH cydy-20231103.xsd EX-101.SCH 3130
5 EX-101.LAB cydy-20231103_lab.xml EX-101.LAB 14108
6 EX-101.PRE cydy-20231103_pre.xml EX-101.PRE 9207
8 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20231103x8k_htm.xml XML 4303
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 231377514
SIC: 2834 Pharmaceutical Preparations